Tesamorelin (a growth hormone releasing hormone analog) can cause mild fluid retention and transient increases in blood pressure in some users
Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) showing promising early evidence for significant weight reduction, improved metabolic markers, and reduced liver fat, but it has not yet received MHRA or EMA approval
Broad Therapeutic Effects : Tirzepatide results in clinically significant improvements in multiple obesity-related complications, including sleep apnea, metabolic dysfunction-associated steatohepatitis, heart failure with preserved ejection fraction, and diabetes prevention [79]
Ultimately, if youre interested in taking a GLP-1 for PCOS, youd want to chat through all of these nuances with your doctor
Full benefits build over time, especially when used weekly or bi-weekly as part of a broader metabolic plan